According to filings with the U.S. Securities and Exchange Commission, Persist AI is raising $4,170,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Karthik Raman played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Persist AI
Developing extended-release PLG drug formulations takes $10M+ and 5-10 years. We enable drug manufacturers and CROs to shorten formulation discovery time by 30-50% by utilizing our automation and machine learning platform. Pharmaceutical companies typically take up to five years to develop long-lasting drug injections to treat chronic conditions such as cancer and diabetes. However, Persist uses AI-driven automation to shorten the formulation development time to just two years, a ~50% reduction. We complete PLGA Microsphere pre-formulation for clients in weeks, not years.

To learn more about Persist AI, visit http://www.persist-ai.com/

Contact:
Karthik Raman, Chief Executive Officer
510-921-0563

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.